Adiposogenital dystrophy differential diagnosis

Jump to navigation Jump to search

Adiposogenital dystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adiposogenital dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Head X Ray

CT

MRI

Vision Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adiposogenital dystrophy differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adiposogenital dystrophy differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adiposogenital dystrophy differential diagnosis

CDC on Adiposogenital dystrophy differential diagnosis

Adiposogenital dystrophy differential diagnosis in the news

Blogs on Adiposogenital dystrophy differential diagnosis

Directions to Hospitals Treating Adiposogenital dystrophy

Risk calculators and risk factors for Adiposogenital dystrophy differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD

Overview

Adiposogenital dystrophy must be differentiated from other diseases that cause polyphagia, obesity, and a delayed puberty such as Prader-Willi syndrome, Bardet-Biedl syndrome, Klinefelter's syndrome and Borjeson syndrome.

Differentiating Adiposogenital Dystrophy from Other Diseases

Disease/Condition Clinical presentation Demographics/History Diagnosis Treatment
Adiposogenital Dystrophy

Partial destruction of hypothalamic nuclei resulting in hormonal dysfunction with obesity, growth retardation, and hypogonadism. Deep brain stimulation may also cause symptoms similar to adiposogenital syndrome [1] [2].

Prevalence is unknown, but it is more common in males [3] [4]

Diagnosis is based on visual field tests, hormonal assays, CT, MRI, autoimmune assays

  • Diet and exercise
  • Radiation
  • Surgery, thermoablation, radiosurgery
  • Hormone replacement[5]
Prader-Willi Syndrome

It presents with hyperphagia, hypogonadism, truncal obesity, intellectual disability, growth delay, hypotonia, almond-shaped palpebral fissures, narrow frontal diameter, thin upper vermilion with downturned corners of the mouth behavioral problems such as anxiety and temper outbursts [6]

Prader Willi Syndrome has a prevalence of 1 in every 1 in 20000 to 1 in 30000 births[7]. Females and males can be equally affected, and there is no difference between races and ethnicities[8]. Most cases of Prader Willi syndrome are sporadic, but familial cases can present when the paternal genes carry a microdeletion in the imprinting center inherited from his mother[9].

  • Hormone replacement[10]
  • Cognitive and behavioral therapy[11]
Bardet-Biedl Syndrome
  • It is a rare autosomal recessive genetic disorder. [12]. Males and females are affected equally[13].
  • Increased in the Arab population of Kuwait at a prevalence of approximately 1:13500[14]
  • Bardet–Biedl syndrome mutations can be diagnosed by genomic sequencing which would show the coding regions of the genes implicated in causing the disease[15].
  • Treatment is symptomatic with focus on managing co=morbidities especially diabetes, hypertension, and obesity [16].
Klinefelter Syndrome
  • It is the most common chromosomal disorder in males with about 1:500 to 1:650 affected. [17] [18].
  • It is treated by testosterone replacement therapy[17].
Börjeson-Forssman-Lehmann syndrome
  • It is a rare X-linked recessive genetic disorder.
  • Females rarely show symptoms or have mild symptom
  • Diagnosis is confirmed by the identification of a PHF6 mutation[19].


References

  1. Tuite PJ, Maxwell RE, Ikramuddin S, Kotz CM, Kotzd CM, Billington CJ; et al. (2005). "Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery". Parkinsonism Relat Disord. 11 (4): 247–52. doi:10.1016/j.parkreldis.2005.01.006. PMID 15878586.
  2. Romito LM, Scerrati M, Contarino MF, Iacoangeli M, Bentivoglio AR, Albanese A (2003) Bilateral high frequency subthalamic stimulation in Parkinson’s disease: long-term neurological follow-up. J Neurosurg Sci 47:119–128 Medline
  3. Babinski-fröhlich syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517244
  4. Burfeind KG, Yadav V, Marks DL. Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation. Curr Neurol Neurosci Rep. 2016 Nov;16(11):98.
  5. Sanchez Jimenez JG, De Jesus O. Hypothalamic Dysfunction. [Updated 2021 Aug 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-
  6. Fermin Gutierrez MA, Mendez MD. Prader-Willi Syndrome. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-.
  7. Pacoricona Alfaro DL, Lemoine P, Ehlinger V, Molinas C, Diene G, Valette M; et al. (2019). "Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center". Orphanet J Rare Dis. 14 (1): 238. doi:10.1186/s13023-019-1214-2. PMC 6829836 Check |pmc= value (help). PMID 31684997.
  8. Bohonowych J, Miller J, McCandless SE, Strong TV (2019). "The Global Prader-Willi Syndrome Registry: Development, Launch, and Early Demographics". Genes (Basel). 10 (9). doi:10.3390/genes10090713. PMC 6770999 Check |pmc= value (help). PMID 31540108.
  9. 9.0 9.1 Butler MG, Manzardo AM, Forster JL (2016). "Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches". Curr Pediatr Rev. 12 (2): 136–66. doi:10.2174/1573396312666151123115250. PMC 6742515 Check |pmc= value (help). PMID 26592417.
  10. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14 (1):10-26. DOI:10.1038/gim.0b013e31822bead0 PMID: 22237428
  11. Passone CBG, Pasqualucci PL, Franco RR, Ito SS, Mattar LBF, Koiffmann CP; et al. (2018). "PRADER-WILLI SYNDROME: WHAT IS THE GENERAL PEDIATRICIAN SUPPOSED TO DO? - A REVIEW". Rev Paul Pediatr. 36 (3): 345–352. doi:10.1590/1984-0462/;2018;36;3;00003. PMC 6202899. PMID 30365815.
  12. Suspitsin EN, Imyanitov EN (2016). "Bardet-Biedl Syndrome". Mol Syndromol. 7 (2): 62–71. doi:10.1159/000445491. PMC 4906432. PMID 27385962.
  13. Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256
  14. Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256
  15. Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256
  16. Forsythe E, Kenny J, Bacchelli C, Beales PL (2018). "Managing Bardet-Biedl Syndrome-Now and in the Future". Front Pediatr. 6: 23. doi:10.3389/fped.2018.00023. PMC 5816783. PMID 29487844.
  17. 17.0 17.1 17.2 Smyth CM, Bremner WJ (1998). "Klinefelter syndrome". Arch Intern Med. 158 (12): 1309–14. doi:10.1001/archinte.158.12.1309. PMID 9645824.
  18. Kanakis GA, Nieschlag E (2018). "Klinefelter syndrome: more than hypogonadism". Metabolism. 86: 135–144. doi:10.1016/j.metabol.2017.09.017. PMID 29382506.
  19. Gécz J, Turner G, Nelson J, Partington M (2006). "The Börjeson-Forssman-Lehman syndrome (BFLS, MIM #301900)". Eur J Hum Genet. 14 (12): 1233–7. doi:10.1038/sj.ejhg.5201639. PMID 16912705.

Template:WH Template:WS